A 42-year-old woman on warfarin for atrial fibrillation presents with recurrent epistaxis over the past 3 days. She reports that the bleeding is from the back of her throat and is difficult to control with pinching. On examination, the anterior nasal cavity appears clear, but blood is trickling from the nasopharynx. Her INR is 4.8 (therapeutic range 2–3). What is the most likely source of bleeding and the most appropriate initial management?

Explanation

## Posterior Epistaxis: Diagnosis and Management ### Clinical Diagnosis **Key Point:** This patient has **posterior epistaxis**, indicated by: - Blood trickling from the nasopharynx (not anterior nares) - Clear anterior nasal cavity on rhinoscopy - Difficulty controlling bleeding with simple pinching (posterior bleeds drain into the pharynx) - Recurrent nature over 3 days (suggests ongoing ooze from a larger vessel) ### Anatomical Basis **High-Yield:** Posterior epistaxis originates from the **sphenopalatine artery (SPA)** and its branches (posterior lateral nasal arteries). The SPA is the terminal branch of the maxillary artery and supplies the posterolateral nasal wall and nasopharynx. ### Risk Factors in This Case 1. **Supratherapeutic anticoagulation:** INR 4.8 (target 2–3 for AF) impairs clot formation 2. **Age 42:** Posterior epistaxis is more common in older patients (>50 years) but can occur at any age with anticoagulation 3. **Warfarin use:** Increases bleeding risk, especially if INR is elevated ### Management Algorithm ```mermaid flowchart TD A[Posterior epistaxis suspected]:::outcome --> B{Bleeding controlled?}:::decision B -->|Yes, mild| C[Reverse anticoagulation<br/>Reduce INR to 2-3]:::action B -->|No, active| D[Posterior packing<br/>or endoscopic cautery]:::action C --> E[Observe 24-48 hrs<br/>Repeat INR]:::action D --> F[Admit for monitoring<br/>Keep packing 3-5 days]:::action E --> G[Discharge with<br/>anticoagulation adjustment]:::outcome F --> H[Remove packing<br/>Reassess bleeding]:::outcome ``` ### Step-by-Step Management 1. **Reverse anticoagulation immediately:** - Reduce warfarin dose or hold temporarily - Consider vitamin K 2.5–5 mg IV (slow infusion, takes 12–24 hours) - Fresh frozen plasma (FFP) 10–15 mL/kg if life-threatening bleeding - Target INR: 2–3 (therapeutic for AF) 2. **Posterior packing (if bleeding persists):** - Foley catheter technique (14–16 Fr) or commercial posterior tampon (Rapid Rhino, Merocel) - Insert catheter through nose, inflate balloon in nasopharynx, secure with tape - Leave in place for 3–5 days (longer than anterior packing due to higher recurrence) - Concurrent anterior packing may be needed 3. **Endoscopic cautery (preferred alternative):** - Sphenopalatine artery ligation or cautery under endoscopic visualization - More definitive than packing; lower recurrence rate - Requires otolaryngology expertise 4. **Supportive care:** - Broad-spectrum antibiotics (amoxicillin-clavulanate) to prevent sinusitis - Analgesia, head elevation - IV fluids if significant blood loss ### Why Anterior Packing Fails **Clinical Pearl:** Anterior packing is ineffective for posterior epistaxis because it does not apply pressure to the SPA territory. Blood continues to flow posteriorly into the nasopharynx, bypassing the anterior pack. ### Mnemonic for Epistaxis Comparison: **ANTE vs. POST** | Feature | Anterior | Posterior | |---------|----------|----------| | **Source** | Kiesselbach's triangle (anterior septum) | Sphenopalatine artery (posterolateral wall) | | **Artery** | Anterior ethmoidal, septal branch of SPA | Sphenopalatine artery (maxillary branch) | | **Age** | Younger (< 50 years) | Older (> 50 years) | | **Bleeding site** | Anterior nares | Nasopharynx, posterior throat | | **Management** | Anterior packing, cautery | Posterior packing, endoscopic cautery, SPA ligation | | **Duration of packing** | 24–48 hours | 3–5 days | | **Recurrence** | ~5–10% | ~10–15% | [cite:Scott-Brown's Otorhinolaryngology 8e Ch 32; Harrison 21e Ch 46]